AI-Driven, Blockchain-Secured Cancer Treatment System

A novel cancer treatment system integrating a pharmaceutical composition comprising a fusion protein dimer and an anticancer agent with AI-driven personalized treatment plans, blockchain-secured storage, and IoT-enabled health monitoring.

The original patent disclosed a pharmaceutical composition for cancer treatment, but its efficacy and accessibility were limited by the lack of personalized treatment approaches, inadequate data security, and insufficient patient monitoring. The new inventive concept addresses these limitations by synergistically combining the patented composition with AI, blockchain, and IoT technologies.

The system comprises a pharmaceutical composition including a fusion protein dimer and an anticancer agent, which is administered in conjunction with a personalized AI-driven treatment plan generated based on a patient's genomic profile. The pharmaceutical composition is stored in a blockchain-secured, decentralized storage system, ensuring secure and transparent access to authorized healthcare professionals. A wearable IoT device tracks the patient's vital signs and health metrics, which are analyzed by a cloud-based server to optimize treatment efficacy. The system enables the creation of personalized cancer treatment models using digital twins and AI simulations, allowing for optimal treatment plan selection.

The new inventive concept introduces the synergistic combination of AI-driven personalized treatment plans, blockchain-secured storage, and IoT-enabled health monitoring with the patented pharmaceutical composition, providing a non-obvious and innovative solution for cancer treatment.

Alternative embodiments may include the use of different AI algorithms, blockchain protocols, or IoT devices. Variations may involve the integration of additional technologies, such as new materials or robotics, to further enhance the system's efficacy and accessibility.

The AI-driven, blockchain-secured cancer treatment system has significant commercial potential in the pharmaceutical and healthcare industries, offering a competitive advantage in personalized cancer treatment and data security. Target markets include hospitals, research institutions, and pharmaceutical companies.